Marker Therapeutics, Inc. (MRKR) — SC 13D/A Filings
All SC 13D/A filings from Marker Therapeutics, Inc.. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
NEA 16 Amends Stake in Marker Therapeutics
— May 17, 2024 Risk: medium
On May 17, 2024, New Enterprise Associates 16, L.P. (NEA 16) filed an amendment to their Schedule 13D concerning Marker Therapeutics, Inc. The filing indicates
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX